Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from NeoGenomics ( (NEO) ).
On August 5, 2025, Elizabeth Floegel resigned from the Board of Directors of NeoGenomics, Inc., effective immediately. Her resignation was not due to any disagreements with the company’s operations, policies, or practices.
The most recent analyst rating on (NEO) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on NeoGenomics stock, see the NEO Stock Forecast page.
Spark’s Take on NEO Stock
According to Spark, TipRanks’ AI Analyst, NEO is a Neutral.
The overall stock score reflects NeoGenomics’ revenue growth and strategic board appointment but is heavily weighed down by ongoing profitability and cash flow issues, technical bearish signals, and valuation concerns.
To see Spark’s full report on NEO stock, click here.
More about NeoGenomics
Average Trading Volume: 2,200,047
Technical Sentiment Signal: Sell
Current Market Cap: $709.2M
For a thorough assessment of NEO stock, go to TipRanks’ Stock Analysis page.